UPDATE: USDA Approves Supplimental Biologics License By: Benzinga via Benzinga March 02, 2015 at 09:28 AM EST Recommended Dose Modifications Withhold dose for any moderate immune-mediated adverse reactions or for symptomatic endocrinopathy ... Read More >> Related Stocks: Bristol-Myers Squibb